Zacks Initiates Coverage of SLSN With Underperform Recommendation

Zacks initiated coverage on Solesence with an "Underperform" rating, citing margin pressure, weak cash flow, rising leverage, and execution challenges. The note points to deterioration in core company fundamentals and a cautious growth outlook. The piece is likely to pressure sentiment in the stock, but it is analyst commentary rather than a company-reported event.

Analysis

Zacks initiated coverage on Solesence with an "Underperform" rating, citing margin pressure, weak cash flow, rising leverage, and execution challenges. The note points to deterioration in core company fundamentals and a cautious growth outlook. The piece is likely to pressure sentiment in the stock, but it is analyst commentary rather than a company-reported event.